Radiotherapy complements immune checkpoint blockade
- PMID: 25873170
- DOI: 10.1016/j.ccell.2015.03.015
Radiotherapy complements immune checkpoint blockade
Abstract
Adaptive immune resistance ablates effective anti-tumor immune responses. In a recent issue of Nature, Victor and colleagues describe that anti-PD-L1 combats adaptive immune resistance upon localized radiation plus anti-CTLA-4 therapy. The superior activity of radiation and dual immune checkpoint blockade is mediated by non-redundant immune mechanisms in cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment on
-
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.Nature. 2015 Apr 16;520(7547):373-7. doi: 10.1038/nature14292. Epub 2015 Mar 9. Nature. 2015. PMID: 25754329 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
